课题基金 / 基金详情

Support for the Conduct of Studies to Evaluate the Impact of Genetic Background and Potential Treatments of SARS-CoV-2 Induced Pneumonia

Support for the Conduct of Studies to Evaluate the Impact of Genetic Background and Potential Treatments of SARS-CoV-2 Induced Pneumonia
支持开展研究以评估遗传背景的影响和 SARS-CoV-2 引起的肺炎的潜在治疗方法
批准号:
10700771
负责人:
BARNEY SPARROW
金额:
$5.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-09-26 至 2023-09-25

项目摘要

项目成果

BARNEY SPARROW的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
COVID19 is a novel zoonosis which has the potential for severe complications. Approximately 20% of affected individuals develop severe pneumonia progressing to acute respiratory distress syndrome (ARDS). Complication rates increase with advanced age, and 6-15% of patients over 70 years die due to COVID19. Severe COVID19 is manifesting primarily as ARDS and respiratory failure, leading to high prevalence of prolonged intensive care utilization, and thus to overwhelmed medical facilities. Currently there is no proven treatment for COVID19 severe disease. Keywords: SARS-CoV-2, COVID-19
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Production of TempOSeq data for the DrugMatrix reference library
  • 批准号:
    10710454
  • 项目类别:
  • 资助金额:
    $110.04万
  • 财政年份:
    2017
  • 负责人:
    BARNEY SPARROW
  • 依托单位:
Systematic Evaluation of the Application of Zebrafish in Toxicology (SEAZIT) Phase 2
  • 批准号:
    10213572
  • 项目类别:
  • 资助金额:
    $100.0万
  • 财政年份:
    2017
  • 负责人:
    BARNEY SPARROW
  • 依托单位:
Evaluation of HepaRG cells as a screen for chemical toxicity and assay optimization
  • 批准号:
    10700772
  • 项目类别:
  • 资助金额:
    $3.76万
  • 财政年份:
    2017
  • 负责人:
    BARNEY SPARROW
  • 依托单位:
海外基金